Balloon dilation in sporadic inclusion body myositis patients with dysphagia

Clinical Medicine Insights: Case Reports

Volumn 6, Issue , 2013, Pages 1-7

  Murata, Ken ya ^a   Kouda, Ken ^a   Tajima, Fumihiro ^a   Kondo, Tomoyoshi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Balloon dilation; Computed pharyngoesophageal manometry; Cricopharyngeal achalasia; Dysphagia; Sporadic inclusion body myositis

Indexed keywords

IMMUNOGLOBULIN;

AGED; ARTICLE; BALLOON DILATATION; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DYSPHAGIA; ESOPHAGUS MANOMETRY; FEMALE; FLUOROSCOPY; HUMAN; MALE; MYOSITIS; PATHOLOGICAL ANATOMY; SPORADIC INCLUSION BODY MYOSITIS; TREATMENT RESPONSE; UPPER ESOPHAGUS SPHINCTER;

EID: 84872697474     PISSN: 11795476     EISSN: None     Source Type: Journal    
DOI: 10.4137/CCRep.S10200     Document Type: Article

References (16)

1. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis. Observations in 40 patients. Brain. 1989;112(Pt 3):727-47.
2. Wintzen AR, Bots GT, de Bakker HM, Hulshof JH, Padberg GW. Dysphagia in inclusion body myositis. J Neurol Neurosurg Psychiatry. 1988;51: 1542-5.
3. Griggs RC, Askanas V, DiMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol. 1995;38:705-13.
4. Seaman WB. Cineroentgenographic observations of the cricopharyngeus. Am J Roentgenol Radium Ther Nucl Med. 1966;96:922-31.
5. Hurwitz AL, Nelson JA, Haddad JK. Oropharyngeal dysphagia Manometric and cine esophagraphic findings. Am J Dig Dis. 1975;20:313-24.
6. Bingham DL. Cricopharyngeal achalasia. Can Med Assoc J. 1963;89: 1071-3.
7. Cook IJ, Blumbergs P, Cash K, Jamieson GG, Shearman DJ. Structural abnormalities of the cricopharyngeus muscle in patients with pharyngeal (Zenker's) diverticulum. J Gastroenterol Hepatol. 1992;7:556-62.
8. Schneider I, Thumfart WF, Pototschnig C, Eckel HE. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. Ann Otol Rhinol Laryngol. 1994;103:31-5.
9. Dalakas MC. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Neurology. 1998;51:S37-45.
10. Cherin P, Pelletier S, Teixeira A, et al. Intravenous immunoglobulin for dysphagia of inclusion body myositis. Neurology. 2002;58:326.
11. Katoh J, Hayakawa M, Ishihara K, Kazumi T. Swallowing rehabilitation using balloon catheter treatment evaluated by videofluorography in an elderly patient with Wallenberg's syndrome. Nippon Ronen Igakkai Zasshi. 2000;37:490-4.
12. Davis D, Nowicki M, Giles H. Cricopharyngeal achalasia responsive to balloon dilation in an infant. South Med J. 2005;98:472-4.
13. Erdeve O, Kologlu M, Saygili B, Atasay B, Arsan S. Primary cricopharyngeal achalasia in a newborn treated by balloon dilatation: a case report and review of the literature. Int J Pediatr Otorhinolaryngol. 2007;71:165-8.
14. Verma A, Bradley WG, Adesina AM, Sofferman R, Pendlebury WW. Inclusion body myositis with cricopharyngeus muscle involvement and severe dysphagia. Muscle Nerve. 1991;14:470-3.
15. Ali GN, Wallace KL, Laundl TM, Hunt DR, deCarle DJ, Cook IJ. Predictors of outcome following cricopharyngeal disruption for pharyngeal dysphagia. Dysphagia. 1997;12:133-9.
16. Dantas RO, Cook IJ, Dodds WJ, Kern MK, Lang IM, Brasseur JG. Biomechanics of cricopharyngeal bars. Gastroenterology. 1990;99: 1269-74.